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Background
The organic cation transporter 3 (OCT3) shows a broad
expression pattern in the nervous system and has been
detected in glial cells and neurons. Here, OCT3 serves as
an additional high-capacity, low-affinity reuptake system
for monoamine neurotransmitters such as norepinephrine,
serotonin and dopamine, and therefore OCT-mediated
uptake has been termed “uptake 2”.
Methods
We used the mouse and human isoforms of OCT3 and
stably expressed them in HEK 293 cells. We measured
OCT3-mediated uptake of the fluorescent substrate
4-Di-1-ASP (4-(4-(dimethylamino)styryl)-N-methylpyridi-
nium (ASP+) in real-time. Uptake of tritiated 1-methyl-4-
phenylpyridinium was measured in comparison to the
fluorescent uptake measurements. We used mass spectro-
metry to assess the phosphorylation status of OCT3.
Results
We show that ASP+ is selectively taken up via OCT3 in
real time. ASP+ uptake allows for sensitive assessment of
transport via OCT3 and hence, we exploited the mode of
action of several OCT3 substrates and transport inhibitors
such as the stress hormone corticosterone. All results with
the fluorescent ASP+ are in line with previously published
reports. Finally, we tested if OCT-mediated uptake is sen-
sitive to phosphorylation and observed that GF109203X
inhibited uptake.
Conclusions
Uptake by OCT3 can be measured with the fluorescent
ligand ASP+; this uptake is comparable to the uptake of
radioactively labeled MPP+. Uptake inhibition by corti-
costerone was comparable using either ASP+ or MPP+
and similar to inhibition of protein kinase C.
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